Startup

PharmEasy’s Valuation Drops by 92%: From $5.6 Billion to Just $456 Million – What Went Wrong

PharmEasy, once a shining star in India’s healthtech industry with a $5.6 billion valuation, has seen a dramatic drop in its worth, now valued at just $456 million. This steep decline has come to light after investor Janus Henderson disclosed it had significantly reduced the value of its shares in PharmEasy. What caused this sharp drop, and what does the future hold for the online pharmacy?
Read more
BusinessNews

Tupperware’s Decline: 3 Key Factors Behind Its Bankruptcy Filing

Tupperware Brands, the iconic home product manufacturer, has officially filed for Chapter 11 bankruptcy protection, marking a significant turn in the company’s history. Once a staple in American households, Tupperware is now struggling to adapt in a rapidly changing market. Here are three reasons contributing to the brand’s downturn. 1. Failure to Evolve Tupperware’s inability to adapt to…
Read more